Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia
Open Access
- 22 November 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 12 (S3), S95-S97
- https://doi.org/10.1002/lt.20965
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Liver transplantation for incidental cholangiocarcinoma: Analysis of the Canadian experienceLiver Transplantation, 2005
- Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar CholangiocarcinomaAnnals of Surgery, 2005
- A Review and Update on CholangiocarcinomaOncology, 2004
- Liver Transplantation for Unresectable Perihilar CholangiocarcinomaSeminars in Liver Disease, 2004
- Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing CholangitisAmerican Journal Of Gastroenterology, 2004
- Spanish Experience in Liver Transplantation for Hilar and Peripheral CholangiocarcinomaAnnals of Surgery, 2004
- Radiochemotherapy and Transplantation Allow Long‐Term Survival For Nonresectable Hilar CholangiocarcinomaAmerican Journal of Transplantation, 2002
- LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1Transplantation, 2000
- “Natural History” of Unresected Cholangiocarcinoma: Patient Outcome After Noncurative InterventionMayo Clinic Proceedings, 1995